![Dolo-650 bribery allegation: Why pharma cos need tight monitoring](https://images.assettype.com/fortuneindia%2F2022-02%2Fc22d5429-80cd-4bf3-ac4d-eda41d6b28a8%2FGettyImages_1237950758_copy.jpg?rect=0,11,3000,1500&w=300&q=95)
Dolo-650 bribery allegation: Why pharma cos need tight monitoring
Dolo-650 manufacturer struck gold during the pandemic; was raided by IT in July, accusing it of bribing doctors through ₹1,000 crore “freebies” to push drug sale during the pandemic
Dolo-650 manufacturer struck gold during the pandemic; was raided by IT in July, accusing it of bribing doctors through ₹1,000 crore “freebies” to push drug sale during the pandemic
The Income Tax Department carried out search and seizure operations on the Bengaluru-based pharmaceutical group on July 6.
Dolo saw a 210% growth while Augmentin 62% in January 2022 as against the same month last year.